Characterization of SafC, a catechol 4-O-methyltransferase involved in saframycin biosynthesis

Applied and Environmental Microbiology

Volumn 73, Issue 11, 2007, Pages 3575-3580

  Nelson, James T ^a   Lee, Jaeheon ^a   Sims, James W ^a   Schmidt, Eric W ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID; CLINICAL DEVELOPMENT; METHYLTRANSFERASE;

BIOSYNTHESIS; DERIVATIVES; PEPTIDES; PHENOLS; REGIOSELECTIVITY; SUBSTRATES;

ENZYMES;

CAFFEIC ACID; CATECHOL; CATECHOL 4 O METHYLTRANSFERASE; DOPA; DOPAMINE; LEVODOPA; METHYLDOPA; METHYLTRANSFERASE; PEPTIDE SYNTHASE; PROTEIN SAFC; SAFRACIN; SAFRAMYCIN; THIOESTER; TRABECTEDIN; UNCLASSIFIED DRUG;

ANTIBIOTICS; CATALYSIS; COLIFORM BACTERIUM; ENZYME ACTIVITY; GENE EXPRESSION; HOMOGENEITY; METHYLATION; PEPTIDE; PHENOLIC COMPOUND; SUBSTRATE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOTECHNOLOGY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE OVEREXPRESSION; METHYLATION; MYXOCOCCUS XANTHUS; NONHUMAN; NONRIBOSOMAL PEPTIDE SYNTHESIS;

CATECHOL O-METHYLTRANSFERASE; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION; ISOQUINOLINES; KINETICS; LEVODOPA; MOLECULAR STRUCTURE; MYXOCOCCUS XANTHUS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

ESCHERICHIA COLI; MYXOCOCCUS XANTHUS;

EID: 34249867714     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00011-07     Document Type: Article

References (39)

1. Arai, T., K. Takahashi, K. Ishiguro, and Y. Mikami. 1980. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C. Gann 71:790-796.
2. Arai, T., K. Yazawa, K. Takahashi, A. Maeda, and Y. Mikami. 1985. Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulae. Antimicrob. Agents. Chemother. 28:5-11.
3. Assicot, M., and C. Bohuon. 1970. Purification and studies of catechol-O-methyltransferase of rat liver. Eur. J. Biochem. 12:490-495.
4. Aune, G. J., T. Furuta, and Y. Pommier. 2002. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action. Anticancer Drugs 13:545-555.
5. Axelrod, J. 1966. Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev. 18:95-113.
6. Axelrod, J., and R. Tomchick. 1958. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 233:702-705.
7. Bentley, K. W. 2006. β-Phenylethylamines and the isoquinoline alkaloids. Nat. Prod. Rep. 23:444-463.
8. Bonifati, V., and G. Meco. 1999. New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease. Pharmacol. Ther. 81:1-36.
9. Chen, J., X. Chen, M. Bois-Choussy, and J. Zhu. 2006. Total synthesis of ecteinascidin 743. J. Am. Chem. Soc. 128:87-89.
10. Chen, X., J. Chen, M. De Paolis, and J. Zhu. 2005. Synthetic studies toward ecteinascidin 743. J. Org. Chem. 70:4397-4408.
11. Cuevas, C., M. Perez, M. J. Martin, J. L. Chicharro, C. Fernandez-Rivas, M. Flores, A. Francesch, P. Gallego, M. Zarzuelo, F. de la Calle, J. Garcia, C. Polanco, I. Rodriguez, and I. Manzanares. 2000. Synthesis of ecteinascidin Et-743 and phthalascidin Pt-650 from cyanosafracin B. Org. Lett. 2:2545-2548.
12. Fayette, J., I. R. Coquard, L. Alberti, H. Boyle, P. Meeus, A. V., Decouvelaere, P. Thiesse, M. P. Sunyach, D. Ranchere, and J. Y. Blay. 2006. Et-743: a novel agent with activity in soft-tissue sarcomas. Curr. Opin. Oncol. 18:347-353.
13. Fischera, D. C. H., N. C. A. Gualda, D. Bachiega, C. S. Carvalho, F. N. Lupo, S. V. Bonotto, M. O. Alves, A. Yogi, S. M. Di Santi, P. E. Avila, K. Kirehgaller, and P. R. H. Moreno. 2004. In vitro screening for antiplasmodial activity of isoquinoline alkaloids from Brazilian plant species. Acta Trop. 92:261-266.
14. Fodor, G., and S. Nagubandi. 1980. Correlation of the von Braun, Ritter, Bischler-Napieralski, Beckmann and Schmidt reactions via nitrilium salt intermediates. Tetrahedron 36:1279-1300.
15. Guldberg, H. C., and C. A. Marsden. 1975. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol. Rev. 27:135-206.
16. He, H. Y., and D. J. Faulkner. 1989. Renieramycin E and renieramycin F from the sponge Reniera sp. Reassignment of the stereochemistry of the renieramycins. J. Org. Chem. 54:5822-5824.
17. Hoffmann, L., S. Maury, M. Bergdoll, L. Thion, M. Erard, and M. Legrand. 2001. Identification of the enzymatic active site of tobacco caffeoyl-coenzyme A O-methyltransferase by site-directed mutagenesis. J. Biol. Chem. 276:36831-36838.
18. Ichiyanagi, T., M. M. Rahman, Y. Kashiwada, Y. Ikeshiro, Y. Shida, Y. Hatano, H. Matsumoto, M. Hirayama, and T. Konishi. 2004. Absorption and metabolism of delphinidin 3-O-β-D-glucoside in rats. Biofactors 21:411-413.
19. Ikeda, Y., H. Idemoto, F. Hirayama, K. Yamamoto, K. Iwao, T. Asao, and T. Munakata. 1983. Safracins, new antitumor antibiotics. I. Producing organism, fermentation and isolation. J. Antibiot. (Tokyo) 36:1279-1283.
20. Irschik, H., W. Trowitzsch-Kienast, K. Gerth, G. Hofle, and H. Reichenbach. 1988. Saframycin Mx1, a new natural saframycin isolated from a myxobaeterium. J. Antibiot. (Tokyo) 41:993-998.
21. ATP channel subunits expressed in HEK-293 cells. Eur. J. Pharmacol. 506:93-100.
22. Kaakkola, S. 2000. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease. Drugs 59:1233-1250.
23. Lu, H., X. Meng, and C. S. Yang. 2003. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab. Dispos. 31:572-579.
24. Männisto, P. T., and S. Kaakkola. 1999. Catechol-O- methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51:593-628.
25. Morishige, T., T. Tsujita, Y. Yamada, and F. Sato. 2000. Molecular characterization of the S-adenosyl-L-methionine:3′- hydroxy-N-methylcoclaurine 4′-O-methyltransferase involved in isoquinoline alkaloid biosynthesis in Coptis japonica. J. Biol. Chem. 275:23398-23405.
26. Palaniswamy, V. A., and S. J. Gould. 1986. Incorporation of 3′-methyltyrosine and 5′-methyl-DOPA into naphthyridinomycin. J. Am. Chem. Soc. 108:5651-5652.
27. Pospiech, A., J. Bletenhader, and T. Schupp. 1996. Two multifunctional peptide synthetases and an O-methyltransferase are involved in the biosynthesis of the DNA-binding antibiotic and antitumour agent saframycin Mx1 from Myxococcus xanthus. Microbiology 142:741-746.
28. Pospiech, A., B. Cluzel, J. Bietenhader, and T. Schupp. 1995. A new Myxococcus xanthus gene cluster for the biosynthesis of the antibiotic saframycin Mx1 encoding a peptide synthetase. Microbiology 141:1793-1803.
29. Rinehart, K. L., T. G. Holt, N. L. Fregeau, J. G. Stroh, P. A. Keifer, F. Sun, L. H. Li, and D. G. Martin. 1990. Ecteinascidin-729, ecteinascidin-743, ecteinascidin-745, ecteinascidin-759a, ecteinascidin-759b, and ecteinascidin-770. Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J. Org. Chem. 55:4512-4515.
30. Ruottinen, H. M., and U. K. Rinne. 1998. COMT inhibition in the treatment of Parkinson's disease. J. Neurol. 245:P25-P34.
31. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
32. Schmidt, E. W., J. T. Nelson, and J. P. Fillmore. 2004. Synthesis of tyrosine derivatives for saframycin MX1 biosynthetic studies. Tetrahedron Lett. 45:3921-3924.
33. Velasco, A., P. Acebo, A. Gomez, C. Schleissner, P. Rodríguez, T. Aparicio, S. Conde, R. Muñoz, F de la Calle, J. L. Garcia, and J. M. Sánchez-Puelles. 2005. Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-2: designing new cytotoxic compounds. Mol. Microbiol. 56:144-154.
34. Vitali, F., K. Zerbe, and J. A. Robinson. 2003. Production of the vancomycin aglycone conjugated to a peptide carrier domain derived from a biosynthetic non-ribosomal peptidc synthetase. Chem. Commun. 21:2718-2719.
35. Ye, Z. H., R. E. Kneusel, U. Matern, and J. E. Varner. 1994. An alternative methylation pathway in lignin biosynthesis in Zinnia. Plant Cell 6:1427-1439.
36. Ye, Z. H., and J. E. Varner. 1995. Differential expression of two O-methyltransferases in lignin biosynthesis in Zinnia elegans. Plant Physiol. 108:459-467.
37. Zewail-Foote, M., V.-S. Li, H. Kohn, D. Bearss, M. Guzman, and L. H. Hurley. 2001. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclcase and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. Chem. Biol. 8:1033-1049.
38. Zhu, B. T., and A. H. Conney. 1998. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58:2269-2277.
39. Ziegler, J., M. L. Diaz-Chavez, R. Kramell, C. Ammer, and T. M. Kutchan. 2005. Comparative macroarray analysis of morphine containing Papaver somniferum and eight morphine free Papaver species identifies an O-methyltransferase involved in benzylisoquinoline biosynthesis. Planta 222:458-471.